Lyra Therapeutics Inc (LYRA) — Cash Flow Reinvestment Rate
Latest as of June 2021:
0.37x
Lyra Therapeutics Inc (LYRA) has a Cash Flow Reinvestment Rate of 0.37x as of June 2021, reinvesting $1.25 Million (capex $625.00K plus investments $-625.00K) from operating cash flow of $3.38 Million. See LYRA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.37x
(Capex + Investments) / Operating CF
Total Reinvested
$1.25 Million
Capex + Investments
Operating Cash Flow
$3.38 Million
USD
Capital Expenditures
$625.00K
USD
Annual Cash Flow Reinvestment Rate for Lyra Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Lyra Therapeutics Inc. See LYRA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow